Twenty-five years of gene therapy for genetic diseases and leukemia: The road to marketing authorization of the first ex vivo gene therapies

- Ex vivo gene therapy for genetic diseases and cancer.
- Genetic engineering of peripheral blood lymphocytes and hematopoietic stem cells.
- Complexities in the development of new therapeutics based on cell and gene manipulation.